«1234567»Seite
13 Artikel mit Literatur, Seite 3 von 13

MEDIZIN: Originalarbeit

Trends kardiovaskulärer Risikofaktoren bei Patienten mit koronarer Herzkrankheit: Ergebnisse der EUROASPIRE I, II und III Surveys in der Region Münster

Trends in Cardiovascular Risk Factors Among Patients With Coronary Heart Disease: Results From the EUROASPIRE I, II, and III Surveys in the Münster Region
Dtsch Arztebl Int 2012; 109(17): 303-10; DOI: 10.3238/arztebl.2012.0303

Prugger, Christof; Heidrich, Jan; Wellmann, Jürgen; Dittrich, Ralf; Brand, Stefan-Martin; Telgmann, Ralph; Breithardt, Günter; Reinecke, Holger; Scheld, Hans; Kleine-Katthöfer, Peter; Heuschmann, Peter U.; Keil, Ulrich

1. Chambless L, Keil U, Dobson A, et al.: Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA Project 1985–1990. Multinational Monitoring of Trends and Determinants in Cardiovascular Disease. Circulation 1997; 96: 3849–59. MEDLINE
2. Collins R, Peto R, MacMahon S, et al.: Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827–38. CrossRef MEDLINE
3. Scandinavian Simvastatin Survival Study Group: Randomised trial of cholesterol lowering in 4 444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383–9. MEDLINE
4.Critchley JA, Capewell S: Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA 2003; 290: 86–97. CrossRef MEDLINE
5. De Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N: Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999; 99: 779–85. MEDLINE
6.Taylor R, Brown A, Ebrahim S, Jolliffe J, Noorani H, Rees K: Exercise-based rehabilitation for patients with coronary heart disease: Systematic Review and Meta-analysis of Randomized Controlled Trials. Am J Med 2004; 116: 682–92. CrossRef MEDLINE
7. Graham I, Atar D, Borch-Johnsen K, et al.: European guidelines on cardiovascular disease prevention in clinical practice: Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007; 14(suppl 2): S1–113. CrossRef MEDLINE
8. EUROASPIRE Study Group: EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. European Action on Secondary Prevention through Intervention to Reduce Events. Eur Heart J 1997; 18: 1569–82. MEDLINE
9. EUROASPIRE Study Group: Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 2001; 22: 554–72. CrossRef MEDLINE
10. EUROASPIRE I and II Group: Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention through Intervention to Reduce Events. Lancet 2001; 357: 995–1001. MEDLINE
11. Enbergs A, Liese A, Heimbach M, et al.: Evaluation of secondary prevention of coronary heart disease. Results of the EUROASPIRE study in the Münster region. Z Kardiol 1997; 86: 284–91. MEDLINE
12. Heidrich J, Liese AD, Kalic M, et al.: Secondary prevention of coronary heart disease. Results from EUROASPIRE I and II in the region of Munster, Germany. Dtsch Med Wochenschr 2002; 127: 667–72. CrossRef MEDLINE
13. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U; EUROASPIRE Study Group. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 2009; 16: 121–37. CrossRef MEDLINE
14. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U; EUROASPIRE Study Group. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 2009; 373: 929–40. CrossRef MEDLINE
15. Wu P, Wilson K, Dimoulas P, Mills EJ: Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health 2006; 6: 300. CrossRef MEDLINE PubMed Central
16. Lancaster T, Stead LF: Individual behavioural counselling for smoking cessation. Cochrane Database of Syst Rev 2005; CD001292. MEDLINE
17.Baigent C, Keech A, Kearney PM, et al.: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267–78. CrossRef MEDLINE
18. Malmberg K, Yusuf S, Gerstein HC, et al.: Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 2000; 102: 1014–9. MEDLINE
19. Prugger C, Wellmann J, Heidrich J, Brand-Herrmann SM, Keil U: Cardiovascular risk factors and mortality in patients with coronary heart disease. Eur J Epidemiol 2008: 23: 731–7. CrossRef MEDLINE
20. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383–93. CrossRef MEDLINE
21. Hubert HB, Feinleib M, McNamara PM, Castelli WP: Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968–77. CrossRef MEDLINE
22. Klein S, Burke LE, Bray GA, et al.: Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 2004; 110: 2952–67. CrossRef MEDLINE
23. Lenfant C: Shattuck lecture—clinical research to clinical practice—lost in translation? N Engl J Med 2003; 349: 868–74. CrossRef MEDLINE
24. Heidrich J, Behrens T, Raspe F, Keil U: Knowledge and perception of guidelines and secondary prevention of coronary heart disease among general practitioners and internists. Results from a physician survey in Germany. Eur J Cardiovasc Prev Rehabil 2005; 12: 521–9. MEDLINE
25. Hobbs FD, Erhardt L: Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey. Fam Pract 2002; 19: 596–604. CrossRef MEDLINE
e1. Sacks FM, Pfeffer MA, Moye LA, et al.: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996; 335: 1001–9. MEDLINE
e2. Critchley J, Capewell S: Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev 2004; CD003041. MEDLINE
e3. Pyorala K, De Backer G, Graham I, Poole-Wilson P, Wood D: Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 1994; 15: 1300–31. MEDLINE
e4. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K: Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis 1998; 140: 199–270. MEDLINE
e5. De Backer G, Ambrosioni E, Borch-Johnsen K, et al.: European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil 2003; 10(Suppl 1): 1–10. MEDLINE
e6. Hughes JR, Stead LF, Lancaster T: Antidepressants for smoking cessation. Cochrane Database Syst Rev 2007; CD000031. MEDLINE
e7. Braunwald E, Domanski MJ, Fowler SE, et al.: Angiotensin-converting-enzyme inhibition in stable coronary artery disease.
N Engl J Med 2004; 351: 2058–68. CrossRef MEDLINE PubMed Central
e8. Law MR, Wald NJ, Rudnicka AR: Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 2003; 326: 1423. CrossRef MEDLINE PubMed Central
e9. Löwel H, Koenig W, Engel S, Hormann A, Keil U: The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment? Results of a population-based myocardial infarction register follow-up study. Diabetologia 2000; 43: 218–26. MEDLINE
e10. Miettinen H, Lehto S, Salomaa V, et al.: Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care 1998; 21: 69–75. MEDLINE
e11. Mukamal KJ, Nesto RW, Cohen MC, et al.: Impact of diabetes on long-term survival after acute myocardial infarction: comparability of risk with prior myocardial infarction. Diabetes Care 2001; 24: 1422–7. MEDLINE
e12. Manson JE, Colditz GA, Stampfer MJ, et al.: A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 1990; 322: 882–9. MEDLINE
e13. Wilson PW, D’Agostino RB, Sullivan L, Parise H, Kannel WB: Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002; 162: 1867–72. CrossRef MEDLINE
e14. Tunstall-Pedoe H, Kuulasmaa K, Mähönen M, et al.: Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999; 353: 1547–57. MEDLINE
e15. Keil U: Das weltweite WHO-MONICA-Projekt: Ergebnisse und Ausblick. Gesundheitswesen 2005; 67: 38–45. CrossRef MEDLINE
e16. Mosca L, Linfante AH, Benjamin EJ, et al.: National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation 2005; 111: 499–510. MEDLINE
e17. Weingarten SR, Henning JM, Badamgarav E, et al.: Interventions used in disease management programmes for patients with chronic illness – which ones will work? Meta-analysis of published reports. BMJ 2002; 325: 925–8. MEDLINE
e18. Koch K, Miksch A, Schürmann C, Joos S, Sawicki PT: The German health care system in international comparison: the primary care physicians´ perspective. Dtsch Arztebl Int 2011; 108(15): 255–61. MEDLINE PubMed Central
«1234567»Seite
13 Artikel mit Literatur, Seite 3 von 13

Login

E-Mail

Passwort


Passwort vergessen?

Registrieren

Eingeloggt als

Suchen in